|
JP2017206538A
|
|
ABC transporter inhibitor
|
|
EP3473243A1
|
|
Foam, screen foamer composition, and evaluation method for same
|
|
WO2017170509A1
|
|
Amorphizing agent, amorphous composition comprising amorphizing agent and utilization thereof
|
|
JP2017186299A
|
|
Anti-tritrichomonas agent
|
|
JP2017223592A
|
|
Foam, composition for screen foamer and method for evaluating the same
|
|
JP2017181387A
|
|
Evaluation method of film formed by pharmaceutical composition
|
|
JP2017178873A
|
|
Anti-tritrichomonas agent
|
|
EP3238710A1
|
|
External composition for screen foamers
|
|
JP2019038748A
|
|
Naphthoquinone derivative and nuclear factor kappa b(nf-kb) inhibitor composed of the derivative
|
|
JP2017101009A
|
|
Anti-acanthamoeba agent and method for producing the same
|
|
JP2016053034A
|
|
Pharmaceutical compositions
|
|
JP2017066056A
|
|
Skin external preparation specified by physical properties
|
|
JP2017066057A
|
|
Skin external preparation and method for producing the same, and method for improving and evaluating emission of active ingredient
|
|
JP2017066055A
|
|
External pharmaceutical composition specified by physical properties
|
|
JP2017066058A
|
|
External pharmaceutical composition excellent in release of active ingredient and method for evaluating release ability of active ingredient
|
|
JP2017002023A
|
|
Antigiardial agent
|
|
JP2015205877A
|
|
External pharmaceutical composition containing antifungal agent and steroid agent
|
|
JP2015199731A
|
|
Usability evaluation method of skin external preparation and skin external preparation discriminated as excellent usability by the same
|
|
JP2015199729A
|
|
external pharmaceutical composition
|
|
JP2015199730A
|
|
Usability evaluation method of skin external preparation and skin external preparation discriminated as excellent usability by the same
|
